Airrosti is a nationally recognized provider of musculoskeletal (MSK) care, delivering clinically led treatment focused on rapid recovery and lasting resolution. With over 20 years of experience and more than 1.8 million patient cases, Airrosti has built a proven model that consistently improves outcomes while reducing unnecessary utilization.
Through Reach by Airrosti, the organization has expanded into a national, hybrid MSK care model that serves as a single front door for care. Reach guides members from initial triage through treatment and recovery across virtual, in clinic, and in network settings, ensuring they start in the right place and receive the appropriate level of care.
Airrosti’s clinical approach focuses on identifying and treating the underlying soft tissue dysfunction driving pain. While many MSK solutions emphasize exercise, content, or engagement, Airrosti delivers clinically directed care designed to resolve the condition. Interventions such as myofascial release are applied with precision based on clinical expertise, enabling faster recovery and more durable outcomes.
By combining clinical direction with coordinated care delivery, Airrosti improves patient experience, accelerates recovery, and lowers total cost of care for employers and health plans.